Home
About
Overview
Sharing Data
ORCID
Help
History (0)
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Search Result Details
Back to Search Results
This page shows the details of why an item matched the keywords from your search.
Search Results
Chapman, Arlene
One or more keywords matched the following items that are connected to
Chapman, Arlene
Item Type
Name
Concept
Receptors, Vasopressin
Academic Article
Acute Response to Tolvaptan in ADPKD: A Window to Predict Long-term Efficacy?
Academic Article
Rationale and design of the TEMPO (Tolvaptan Efficacy and Safety in Management of Autosomal Dominant Polycystic Kidney Disease and its Outcomes) 3-4 Study.
Academic Article
Tolvaptan in autosomal dominant polycystic kidney disease: three years' experience.
Academic Article
Tolvaptan in patients with autosomal dominant polycystic kidney disease.
Academic Article
Albuminuria and tolvaptan in autosomal-dominant polycystic kidney disease: results of the TEMPO 3:4 Trial.
Academic Article
Tolvaptan and Kidney Pain in Patients With Autosomal Dominant Polycystic Kidney Disease: Secondary Analysis From a Randomized Controlled Trial.
Academic Article
Effect of Tolvaptan in Autosomal Dominant Polycystic Kidney Disease by CKD Stage: Results from the TEMPO 3:4 Trial.
Academic Article
Urine Osmolality, Response to Tolvaptan, and Outcome in Autosomal Dominant Polycystic Kidney Disease: Results from the TEMPO 3:4 Trial.
Academic Article
Tolvaptan suppresses monocyte chemotactic protein-1 excretion in autosomal-dominant polycystic kidney disease.
Academic Article
Multicenter, open-label, extension trial to evaluate the long-term efficacy and safety of early versus delayed treatment with tolvaptan in autosomal dominant polycystic kidney disease: the TEMPO 4:4 Trial.
Academic Article
Can we further enrich autosomal dominant polycystic kidney disease clinical trials for rapidly progressive patients? Application of the PROPKD score in the TEMPO trial.
Academic Article
Tolvaptan in Later-Stage Autosomal Dominant Polycystic Kidney Disease.
Academic Article
A Practical Guide for Treatment of Rapidly Progressive ADPKD with Tolvaptan.
Academic Article
Plasma copeptin levels predict disease progression and tolvaptan efficacy in autosomal dominant polycystic kidney disease.
Academic Article
Multicenter Study of Long-Term Safety of Tolvaptan in Later-Stage Autosomal Dominant Polycystic Kidney Disease.
Concept
Antidiuretic Hormone Receptor Antagonists
Search Criteria
Receptors Vasopressin